Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
In conclusion, we construct a novel prognostic model which provides new insights into glioma prognosis. The PDPN and TIMP1 may serve as potential biomarkers for prognosis of glioma.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | China Health | Databases & Libraries | Genetics | Glioma | Neurology